News
HSA Adverse Drug Reaction News 2023 Sept, Vol.25 No.2
Professionals
Allied Health Professionals
Dental Practitioners
Doctors
Nurses
Pharmacists
TCM Practitioners
22 September 2023
Access and read HSA's September 2023 bulletin which covers adverse events for health products and other news.
HSA Adverse Drug Reaction News 2023 Sept, Vol.25 No.2
The aim of the news bulletin is to increase the awareness of adverse events related to health products amongst healthcare professionals, and to promote adverse event reporting related to health products.
This issue includes the following topics:
Reminder on the risk of pholcodine-associated perioperative anaphylaxis with neuromuscular blocking agents
Biotin interference with thyroid function tests
HSA is assessing the potential risk of suicidal thoughts and self-harm with glucagon-like peptide-1 receptor agonists (GLP-1 RA)
Reports of issues associated with the use of Cathejell (lignocaine 2% gel)